These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20518136)

  • 21. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteonecrosis in the jaws of patients who are using oral biphosphonates to treat osteoporosis.
    Dello Russo NM; Jeffcoat MK; Marx RE; Fugazzotto P
    Int J Oral Maxillofac Implants; 2007; 22(1):146-53. PubMed ID: 17340909
    [No Abstract]   [Full Text] [Related]  

  • 23. Bisphosphonate associated osteonecrosis of the jaws and endodontic treatment: two case reports.
    Fugazzotto PA; Lightfoot S
    J Mass Dent Soc; 2006; 55(2):5. PubMed ID: 16937899
    [No Abstract]   [Full Text] [Related]  

  • 24. Osteoporosis treatments and adverse events.
    Solomon DH; Rekedal L; Cadarette SM
    Curr Opin Rheumatol; 2009 Jul; 21(4):363-8. PubMed ID: 19412101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment protocols of bisphosphonate-related osteonecrosis of the jaws.
    Kyrgidis A; Koloutsos G; Vahtsevanos K
    Head Neck; 2009 Aug; 31(8):1112-3; author reply 1113-4. PubMed ID: 19572289
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug induced osteonecrosis of the jaws.
    Weeda LW
    J Tenn Dent Assoc; 2006; 86(2):18-9. PubMed ID: 16895006
    [No Abstract]   [Full Text] [Related]  

  • 27. Tooth extraction: Is it inciting event or sequela of osteonecrosis of the jaws associated with intravenous bisphosphonates?
    Altundag K; Bulut N; Tezcan E; Ozen M; Purnak T
    J Oral Maxillofac Surg; 2007 Jan; 65(1):154. PubMed ID: 17174785
    [No Abstract]   [Full Text] [Related]  

  • 28. Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures?
    Fusco V; Baraldi A; Loidoris A; Ciuffreda L; Galassi C; Goia F; Scoletta M; Berrone S; Benech A; Ortega C; Berruti A;
    J Oral Maxillofac Surg; 2009 Aug; 67(8):1775. PubMed ID: 19615599
    [No Abstract]   [Full Text] [Related]  

  • 29. Implications of bisphosphonate use for the dentist: an introduction.
    Kurtzman GM; Silverstein LH; Peden J; Shatz PC
    Dent Today; 2006 Jun; 25(6):80, 82-5; quiz 85. PubMed ID: 16792113
    [No Abstract]   [Full Text] [Related]  

  • 30. Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces.
    Naik NH; Russo TA
    Clin Infect Dis; 2009 Dec; 49(11):1729-32. PubMed ID: 19886792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.
    Radfar L; Masood F
    J Okla Dent Assoc; 2008; 99(7):28-9. PubMed ID: 18595621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A physician discusses the dental impact of oral bisphosphonates.
    Roudebush CP
    J Indiana Dent Assoc; 2006-2007 Winter; 85(4):4-5. PubMed ID: 17489111
    [No Abstract]   [Full Text] [Related]  

  • 33. [Jaw necrosis following treatment with biphosphonates--the dose is of crucial significance for the risk].
    Langdahl BL; Hitz M; Melsen B; Pinholt EM
    Ugeskr Laeger; 2009 Mar; 171(13):1103; author reply 1103. PubMed ID: 19330957
    [No Abstract]   [Full Text] [Related]  

  • 34. Bisphosphonate therapy and dental treatment.
    Phillips G
    J Mich Dent Assoc; 2009 Aug; 91(8):40, 42-5. PubMed ID: 19722373
    [No Abstract]   [Full Text] [Related]  

  • 35. [Atrial fibrillation during bisphosphonate therapy. side effects or coincidental finding?].
    Ringe JD
    MMW Fortschr Med; 2009 Mar; 151(10):7. PubMed ID: 19472655
    [No Abstract]   [Full Text] [Related]  

  • 36. Osteonecrosis of the jaws: maxillofacial recommendations for bisphosphonate prescribers.
    Landis BN; Dojcinovic I; Richter M; Hugentobler M
    J Intern Med; 2007 Jan; 261(1):101-2. PubMed ID: 17222173
    [No Abstract]   [Full Text] [Related]  

  • 37. Bisphosphonate related osteonecrosis of the jaws.
    Fung E
    J Rheumatol; 2009 Feb; 36(2):450; author reply 453. PubMed ID: 19208578
    [No Abstract]   [Full Text] [Related]  

  • 38. Alveolar bone and the bisphosphonates.
    Cheng A; Daly CG; Logan RM; Stein B; Goss AN
    Aust Dent J; 2009 Sep; 54 Suppl 1():S51-61. PubMed ID: 19737268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complication related to bisphosphonate therapy: osteonecrosis of the jaw.
    Lee J
    J Infus Nurs; 2009; 32(6):330-5. PubMed ID: 19918142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update.
    Ruggiero SL; Dodson TB; Assael LA; Landesberg R; Marx RE; Mehrotra B;
    Aust Endod J; 2009 Dec; 35(3):119-30. PubMed ID: 19961450
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.